Moderna
MRNA
#1332
Rank
C$19.13 B
Marketcap
$49.48
Share price
-2.03%
Change (1 day)
-65.50%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of December 2024 : C$1.07 Billion

According to Moderna 's latest financial reports the company's total debt is C$1.07 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2024-12-31C$1.07 B-34.98%
2023-12-31C$1.64 B1.25%
2022-12-31C$1.62 B39.49%
2021-12-31C$1.16 B286.31%
2020-12-31C$0.30 B74.8%
2019-12-31C$0.17 B278.96%
2018-12-31C$45.61 M131.3%
2017-12-31C$19.72 M17.41%
2016-12-31C$16.79 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$0.68 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$53.53 B 4,868.01%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.79 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.86 B 73.50%๐Ÿ‡บ๐Ÿ‡ธ USA
C$45.09 B 4,084.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$0.75 B-29.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$52.84 B 4,804.15%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA